CCRM Australia: Lessons from the front line of commercialization

by CCRM Australia | Oct 1, 2025

Silvio Tiziani, MBA, GAICD, is the CEO of CCRM Australia, leading efforts to bridge the gap between research and industry in regenerative medicine. With extensive experience across academia, health, and industry, he has successfully developed strategic partnerships,...

Regenerative immunotherapy: Hope for chronic autoimmune diseases

by Guest | Sep 16, 2025

Ellie Kroeger is a writer and researcher currently studying the vaginal microbiome and vaginal microbiota transplants. She holds a B.Sc. in human biology from the University of Southern California. You can connect with her via her website...

Canada’s regenerative revolution: Why AI is the catalyst

by Guest | Sep 4, 2025

Sanat Khanna holds a Bachelor of Science in Biotechnology from India and recently completed an Advanced Diploma in Biotechnology at Centennial College. He has hands-on experience in scientific research, project coordination, and science communication, having worked in...

Summer by Design: A launchpad for future entrepreneurs and industry scientists

by Guest | Aug 14, 2025

Sylvia Almeida is a PhD candidate in the Department of Molecular Genetics at the University of Toronto. Her research leverages chemical genomics to uncover novel therapeutic strategies for human disease in collaboration with other Canadian and international academic...

Sustainability in CGT: Evaluating LCA and manufacturing approaches

by Laya Kiani | Jul 30, 2025

In recent years, the field of cell and gene therapy (CGT) has garnered significant attention for its groundbreaking potential to treat previously untreatable diseases. This excitement, however, is offset by growing awareness of the environmental footprint of these...

Regenerative Medicine News Under the Microscope – Summer Edition, Part I

by Lyla El-Fayomi | Jul 17, 2025

The volume of clinical updates I encounter every month is steadily but very noticeably growing month over month! There are lots to get through, so in this rapid-fire edition of RMNU🔬, you’ll find short summaries on all the biggest headlines of the summer’s first half....

Commercializing regenerative medicine: My Summer by Design 2025 experience

by Guest | Jul 3, 2025

Maria Tsalkitzidou is a PhD student at Lund University in Sweden. Her research focuses on neural stem cells and their potential for cell therapy applications for neurological disorders. She specializes in using advanced multiomic techniques to study and characterize...

Right Turn: #pinksocks, diabetes news and other ramblings

by Stacey Johnson | Jun 24, 2025

Pink. What does the colour pink make you think of? It might make you think of activism, acceptance, awareness and allyship based on how it has been adopted by various groups around the world. Pink makes me think of the American singer, songwriter and activist P!nk....

New turn for stem cell therapy: How tiny messengers are about to change the game

by Peace Chukwu | Jun 18, 2025

For decades, exosomes were seen as the cell’s garbage collection system. The understanding of their function was limited to cellular waste disposal, removing unwanted substances from the cell. Now, researchers are making the shift from using whole stem cells to...

Lowering CAR T costs: Paths to more affordable cell therapies

by Anis Fahandej-Sadi | Jun 5, 2025

Cancer treatment has advanced dramatically, but a central challenge remains: the newest tools in our arsenal are shockingly expensive. CAR T-cell therapies exemplify this—they’re amazing at fighting blood cancers, but a single treatment costs upwards of...